Trial Profile
A single-centre, randomised trial evaluating the ablative effects of microbubble-enhancing contrast agent SonoVue with high-intensity focussed ultrasound for uterine fibroids
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 Nov 2015
Price :
$35
*
At a glance
- Drugs Sulfur hexafluoride (Primary)
- Indications Uterine leiomyoma
- Focus Diagnostic use
- 27 Nov 2015 New trial record